Are Cases Containing Combination Products Represented Differently in the NDA Listing?
(Doc ID 2957293.1)
Last updated on JULY 31, 2023
Applies to:
Oracle Life Sciences Argus Safety - Version 8.2.3.1 and laterInformation in this document applies to any platform.
Goal
Have changes been made to the New Drug Application (NDA) report in Argus to represent cases containing combination products?
Solution
To view full details, sign in with your My Oracle Support account. |
|
Don't have a My Oracle Support account? Click to get started! |
In this Document
Goal |
Solution |